Valuation: Assertio Holdings

Market Cap 15Cr 14Cr 13Cr 11Cr 22Cr 1.47TCr 22Cr 151.89Cr 59Cr 747.38Cr 57Cr 56Cr 2.4TCr P/E 2024
-3.79x
P/E 2025 -1.91x
Enterprise Value 13Cr 11Cr 11Cr 9.74Cr 18Cr 1.25TCr 19Cr 128.73Cr 50Cr 633.44Cr 48Cr 47Cr 2.04TCr EV / Sales 2024
0.19x
EV / Sales 2025 0.3x
Free-Float
99.05%
Yield 2024 *
-
Yield 2025 -
1 day+0.09%
6 months+27.65%
Current year+159.10%
Current year 9.11
Extreme 9.11
23.5
1 year 8.61
Extreme 8.61
23.5
3 years 7.71
Extreme 7.705496
39
5 years 7.71
Extreme 7.705496
120.15
10 years 7.71
Extreme 7.705496
1,566.6
Director TitleAgeSince
Director/Board Member 26 16/06/2026
Director/Board Member - 16/06/2026
Date Insider Type Main position Quantity % Market Cap. Importance
13/05/26 Don

Chairman

-13,332 0.2069%
05/05/26 Free

Chairman

4,851 0.0753%
05/05/26 Free

Director

4,851 0.0753%
Change 5-day change 1-year change 3-year change Capi.($)
+0.09%-.--%+76.43%-39.04% 15Cr
-1.61%+1.72%+38.30%+106.93% 1,06000Cr
-0.76%-0.84%+35.21%+62.70% 62TCr
+0.39%+4.81%+17.81%+83.77% 48TCr
-0.29%-0.99%+64.79%+37.06% 35TCr
-2.03%+1.06%+21.08%+42.16% 35TCr
-1.92%-0.29%+10.54%+33.20% 27TCr
-2.36%-1.16%-7.14%+8.68% 25TCr
-1.37%+0.04%+38.29%+52.33% 22TCr
+0.17%-0.27%+24.40%+96.82% 18TCr
Average -0.95%+0.45%+31.97%+48.46% 37.88TCr
Weighted average by Cap. -1.05%+0.74%+30.43%+68.82%

Financials

2024 2025
Net sales 12Cr 11Cr 10Cr 9.46Cr 18Cr 1.21TCr 18Cr 124.98Cr 49Cr 614.99Cr 47Cr 46Cr 1.98TCr 12Cr 11Cr 9.89Cr 8.98Cr 17Cr 1.15TCr 17Cr 118.73Cr 46Cr 584.24Cr 45Cr 44Cr 1.88TCr
Net income -2.16Cr -1.93Cr -1.8Cr -1.63Cr -3.07Cr -209.01Cr -3.1Cr -22Cr -8.44Cr -106.21Cr -8.1Cr -7.93Cr -341.58Cr -3.04Cr -2.71Cr -2.53Cr -2.3Cr -4.33Cr -294.18Cr -4.37Cr -30Cr -12Cr -149.49Cr -11Cr -11Cr -480.76Cr
Net Debt -5.98Cr -5.34Cr -4.98Cr -4.52Cr -8.51Cr -579.05Cr -8.6Cr -60Cr -23Cr -294.24Cr -22Cr -22Cr -946.3Cr -2.32Cr -2.07Cr -1.93Cr -1.75Cr -3.3Cr -224.23Cr -3.33Cr -23Cr -9.06Cr -113.94Cr -8.69Cr -8.5Cr -366.44Cr
Projected Income Statement - Annual - Assertio Holdings
Logo Assertio Holdings
Assertio Holdings Inc is a United States-based commercial pharmaceutical company. The Company focused on the marketing and distribution of branded prescription medicines across several therapeutic categories. It maintains a portfolio that includes treatments for neurology disorders, inflammatory conditions, pain management, and oncology. Its activities involve acquiring, licensing, and integrating approved pharmaceutical products, followed by commercialization within the healthcare market. Its operating approach centers on identifying products that have established regulatory clearance and advancing their reach through targeted sales, medical education, and market access efforts. It manages product lifecycles through activities such as labeling updates, supply coordination, and engagement with healthcare professionals and payers.
Employees
53
  1. Stock Market
  2. Stocks
  3. ASRT Stock